GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioLASCO Taiwan Co Ltd (ROCO:6662) » Definitions » Price-to-Owner-Earnings

BioLASCO Taiwan Co (ROCO:6662) Price-to-Owner-Earnings : 152.17 (As of May. 16, 2024)


View and export this data going back to 2018. Start your Free Trial

What is BioLASCO Taiwan Co Price-to-Owner-Earnings?

As of today (2024-05-16), BioLASCO Taiwan Co's share price is NT$35.00. BioLASCO Taiwan Co's Owner Earnings per Share (TTM) ended in Mar. 2024 was NT$0.23. It's Price-to-Owner-Earnings for today is 152.17.


The historical rank and industry rank for BioLASCO Taiwan Co's Price-to-Owner-Earnings or its related term are showing as below:

ROCO:6662' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 19.94   Med: 47.38   Max: 377.38
Current: 160

During the past 10 years, the highest Price-to-Owner-Earnings of BioLASCO Taiwan Co was 377.38. The lowest was 19.94. And the median was 47.38.


ROCO:6662's Price-to-Owner-Earnings is ranked worse than
85.71% of 168 companies
in the Biotechnology industry
Industry Median: 34.045 vs ROCO:6662: 160.00

As of today (2024-05-16), BioLASCO Taiwan Co's share price is NT$35.00. BioLASCO Taiwan Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was NT$1.81. Therefore, BioLASCO Taiwan Co's PE Ratio for today is 19.34.

As of today (2024-05-16), BioLASCO Taiwan Co's share price is NT$35.00. BioLASCO Taiwan Co's EPS without NRI for the trailing twelve months (TTM) ended in was NT$1.81. Therefore, BioLASCO Taiwan Co's PE Ratio without NRI for today is 19.38.

During the past 10 years, BioLASCO Taiwan Co's highest PE Ratio without NRI was 29.31. The lowest was 11.10. And the median was 17.58.


BioLASCO Taiwan Co Price-to-Owner-Earnings Historical Data

The historical data trend for BioLASCO Taiwan Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioLASCO Taiwan Co Price-to-Owner-Earnings Chart

BioLASCO Taiwan Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 23.32 36.31 147.56

BioLASCO Taiwan Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 375.60 137.00 62.28 147.56 -

Competitive Comparison of BioLASCO Taiwan Co's Price-to-Owner-Earnings

For the Biotechnology subindustry, BioLASCO Taiwan Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioLASCO Taiwan Co's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioLASCO Taiwan Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where BioLASCO Taiwan Co's Price-to-Owner-Earnings falls into.



BioLASCO Taiwan Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

BioLASCO Taiwan Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=35.00/0.23
=152.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioLASCO Taiwan Co  (ROCO:6662) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


BioLASCO Taiwan Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of BioLASCO Taiwan Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


BioLASCO Taiwan Co (ROCO:6662) Business Description

Traded in Other Exchanges
N/A
Address
3rd Floor, 316 Chong-yang Road, Taipei, TWN, 115
BioLASCO Taiwan Co Ltd is a biological experimental development company. The company has produced strains of laboratory rats and mice, including outbreed stocks, inbreed strains, and immunedeficient models. It offers reagent kit and equipment which include Allentown, Biomedical data system, PLAS LABS.

BioLASCO Taiwan Co (ROCO:6662) Headlines

No Headlines